Ketryx, founded in 2021 and headquartered in Somerville, Massachusetts, specializes in developing AI-powered regulatory compliance platforms for the medical device industry. Their solutions integrate seamlessly with popular development tools like Jira and GitHub, automating documentation and enforcing quality management systems to streamline compliance processes. In November 2023, Ketryx secured $14 million in Series A funding led by Lightspeed Venture Partners, bringing their total funding to $18 million. The company’s mission is to accelerate the development of safe and reliable medical software by reducing the complexity of regulatory adherence. As of January 2025, Ketryx’s platform has been adopted by leading MedTech manufacturers, impacting over 20 million patients worldwide. The leadership team includes CEO and Founder Erez Kaminski, CTO and Founder Jan Pöschko, and COO John Koontz, who collectively bring extensive experience in software development, regulatory compliance, and AI/ML applications in healthcare. Ketryx continues to innovate, recently introducing AI capabilities that automate the creation of requirements and traceability links, further enhancing efficiency in medical software development. (February 2025)